Professor / University of Southampton
University of Southampton, Highfield Campus Southampton, England, United Kingdom SO17 1BJ
Max Crispin runs the Glycoprotein Therapeutics Laboratory which is predominantly focused on developing anti-viral vaccines and new antibody-based therapies against cancer.
Max Crispin focuses on the development of glycoprotein-based immunotherapies and vaccines. His lab is looking at the structure of the glycan modification of HIV Envelope spike as they form epitopes for broadly neutralizing antibodies, and investigates the relationship between the glycosylation of immunogens to that of native virions. By doing this, the laboratory is helping guide the development of lead vaccine candidates.